Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial | |
Yang, Lu; Yang, Sheng; Liu, Yutao; Li, Junling; Hu, Xingsheng; Wang, Yalei; Zhang, Yan; Wang, Yan | |
2018 | |
卷号 | 9期号:6页码:693-698 |
关键词 | Acquired resistance EGFR-tyrosine kinase inhibitors non-small cell lung cancer phase II study TS-1 |
ISSN号 | 1759-7706 |
DOI | 10.1111/1759-7714.12632 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6360328 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Yang, Lu,Yang, Sheng,Liu, Yutao,et al. Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial[J],2018,9(6):693-698. |
APA | Yang, Lu.,Yang, Sheng.,Liu, Yutao.,Li, Junling.,Hu, Xingsheng.,...&Wang, Yan.(2018).Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial.,9(6),693-698. |
MLA | Yang, Lu,et al."Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial".9.6(2018):693-698. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论